|
1
|
Unoki M, Nishidate T and Nakamura Y:
ICBP90, an E2F-1 target, recruits HDAC1 and binds to methyl-CpG
through its SRA domain. Oncogene. 23:7601–7610. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jin W, Chen L, Chen Y, Xu SG, Di GH, Yin
WJ, Wu J and Shao ZM: UHRF1 is associated with epigenetic silencing
of BRCA1 in sporadic breast cancer. Breast Cancer Res Treat.
123:359–373. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Achour M, Jacq X, Rondé P, Alhosin M,
Charlot C, Chataigneau T, Jeanblanc M, Macaluso M, Giordano A,
Hughes AD, et al: The interaction of the SRA domain of ICBP90 with
a novel domain of DNMT1 is involved in the regulation of VEGF gene
expression. Oncogene. 27:2187–2197. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bronner C, Achour M, Arima Y, Chataigneau
T, Saya H and Schini-Kerth VB: The UHRF family: Oncogenes that are
drugable targets for cancer therapy in the near future? Pharmacol
Ther. 115:419–434. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Berkyurek AC, Suetake I, Arita K,
Takeshita K, Nakagawa A, Shirakawa M and Tajima S: The DNA
methyltransferase Dnmt1 directly interacts with the SET and RING
finger-associated (SRA) domain of the multifunctional protein Uhrf1
to facilitate accession of the catalytic center to hemi-methylated
DNA. J Biol Chemistry. 289:379–386. 2014. View Article : Google Scholar
|
|
6
|
Alhosin M, Omran Z, Zamzami MA, Al-Malki
AL, Choudhry H, Mousli M and Bronner C: Signalling pathways in
UHRF1-dependent regulation of tumor suppressor genes in cancer. J
Exp Clin Cancer Res. 35:1742016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bronner C, Krifa M and Mousli M:
Increasing role of UHRF1 in the reading and inheritance of the
epigenetic code as well as in tumorogenesis. Biochem Pharmacol.
86:1643–1649. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Alhosin M, Sharif T, Mousli M,
Etienne-Selloum N, Fuhrmann G, Schini-Kerth VB and Bronner C:
Down-regulation of UHRF1, associated with re-expression of tumor
suppressor genes, is a common feature of natural compounds
exhibiting anti-cancer properties. J Exp Clin Cancer Res.
30:412011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bronner C, Chataigneau T, Schini-Kerth VB
and Landry Y: The ‘Epigenetic Code Replication Machinery’, ECREM: A
promising drugable target of the epigenetic cell memory. Curr Med
Chemistry. 14:2629–2641. 2007. View Article : Google Scholar
|
|
10
|
Liu X, Gao Q, Li P, Zhao Q, Zhang J, Li J,
Koseki H and Wong J: UHRF1 targets DNMT1 for DNA methylation
through cooperative binding of hemi-methylated DNA and methylated
H3K9. Nat Commun. 4:15632013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nady N, Lemak A, Walker JR, Avvakumov GV,
Kareta MS, Achour M, Xue S, Duan S, Allali-Hassani A, Zuo X, et al:
Recognition of multivalent histone states associated with
heterochromatin by UHRF1 protein. J Biol Chem. 286:24300–24311.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Karagianni P, Amazit L, Qin J and Wong J:
ICBP90, a novel methyl K9 H3 binding protein linking protein
ubiquitination with heterochromatin formation. Mol Cell Biol.
28:705–717. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Papait R, Pistore C, Grazini U, Babbio F,
Cogliati S, Pecoraro D, Brino L, Morand AL, Dechampesme AM, Spada
F, et al: The PHD domain of Np95 (mUHRF1) is involved in
large-scale reorganization of pericentromeric heterochromatin. Mol
Biol Cell. 19:3554–3563. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jenkins Y, Markovtsov V, Lang W, Sharma P,
Pearsall D, Warner J, Franci C, Huang B, Huang J, Yam GC, et al:
Critical role of the ubiquitin ligase activity of UHRF1, a nuclear
RING finger protein, in tumor cell growth. Mol Biol Cell.
16:5621–5629. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Citterio E, Papait R, Nicassio F, Vecchi
M, Gomiero P, Mantovani R, Di Fiore PP and Bonapace IM: Np95 is a
histone-binding protein endowed with ubiquitin ligase activity. Mol
Cell Biol. 24:2526–2535. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li M, Chen D, Shiloh A, Luo J, Nikolaev
AY, Qin J and Gu W: Deubiquitination of p53 by HAUSP is an
important pathway for p53 stabilization. Nature. 416:648–653. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Qin W, Leonhardt H and Spada F: Usp7 and
Uhrf1 control ubiquitination and stability of the maintenance DNA
methyltransferase Dnmt1. J Cell Biochem. 112:439–444. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Felle M, Joppien S, Németh A, Diermeier S,
Thalhammer V, Dobner T, Kremmer E, Kappler R and Längst G: The
USP7/Dnmt1 complex stimulates the DNA methylation activity of Dnmt1
and regulates the stability of UHRF1. Nucleic Acids Res.
39:8355–8365. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ma H, Chen H, Guo X, Wang Z, Sowa ME,
Zheng L, Hu S, Zeng P, Guo R, Diao J, et al: M phase
phosphorylation of the epigenetic regulator UHRF1 regulates its
physical association with the deubiquitylase USP7 and stability.
Proc Natl Acad Sci USA. 109:pp. 4828–4833. 2012; View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Arita K, Ariyoshi M, Tochio H, Nakamura Y
and Shirakawa M: Recognition of hemi-methylated DNA by the SRA
protein UHRF1 by a base-flipping mechanism. Nature. 455:818–821.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Avvakumov GV, Walker JR, Xue S, Li Y, Duan
S, Bronner C, Arrowsmith CH and Dhe-Paganon S: Structural basis for
recognition of hemi-methylated DNA by the SRA domain of human
UHRF1. Nature. 455:822–825. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bostick M, Kim JK, Estève PO, Clark A,
Pradhan S and Jacobsen SE: UHRF1 plays a role in maintaining DNA
methylation in mammalian cells. Science. 317:1760–1764. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Unoki M, Brunet J and Mousli M: Drug
discovery targeting epigenetic codes: The great potential of UHRF1,
which links DNA methylation and histone modifications, as a drug
target in cancers and toxoplasmosis. Biochem Pharmacol.
78:1279–1288. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hervouet E, Lalier L, Debien E, Cheray M,
Geairon A, Rogniaux H, Loussouarn D, Martin SA, Vallette FM and
Cartron PF: Disruption of Dnmt1/PCNA/UHRF1 interactions promotes
tumorigenesis from human and mice glial cells. PLoS One.
5:e113332010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pacaud R, Brocard E, Lalier L, Hervouet E,
Vallette FM and Cartron PF: The DNMT1/PCNA/UHRF1 disruption induces
tumorigenesis characterized by similar genetic and epigenetic
signatures. Sci Reports. 4:42302014. View Article : Google Scholar
|
|
26
|
Ge TT, Yang M, Chen Z, Lou G and Gu T:
UHRF1 gene silencing inhibits cell proliferation and promotes cell
apoptosis in human cervical squamous cell carcinoma CaSki cells. J
Ovarian Res. 9:422016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wan X, Yang S, Huang W, Wu D, Chen H, Wu
M, Li J, Li T and Li Y: UHRF1 overexpression is involved in cell
proliferation and biochemical recurrence in prostate cancer after
radical prostatectomy. J Exp Clin Cancer Res. 35:342016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Abu-Alainin W, Gana T, Liloglou T,
Olayanju A, Barrera LN, Ferguson R, Campbell F, Andrews T, Goldring
C, Kitteringham N, et al: UHRF1 regulation of the Keap1-Nrf2
pathway in pancreatic cancer contributes to oncogenesis. J
Pathology. 238:423–433. 2016. View Article : Google Scholar
|
|
29
|
UHRF1 is an oncogene that promotes DNA
hypomethylation. Cancer Discov. 4:OF92014. View Article : Google Scholar
|
|
30
|
Guan D, Factor D, Liu Y, Wang Z and Kao
HY: The epigenetic regulator UHRF1 promotes ubiquitination-mediated
degradation of the tumor-suppressor protein promyelocytic leukemia
protein. Oncogene. 32:3819–3828. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Babbio F, Pistore C, Curti L, Castiglioni
I, Kunderfranco P, Brino L, Oudet P, Seiler R, Thalman GN, Roggero
E, et al: The SRA protein UHRF1 promotes epigenetic crosstalks and
is involved in prostate cancer progression. Oncogene. 31:4878–4887.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhou L, Shang Y, Jin Z, Zhang W, Lv C,
Zhao X, Liu Y, Li N and Liang J: UHRF1 promotes proliferation of
gastric cancer via mediating tumor suppressor gene
hypermethylation. Cancer Biol Ther. 16:1241–1251. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Qu X, Davison J, Du L, Storer B, Stirewalt
DL, Heimfeld S, Estey E, Appelbaum FR and Fang M: Identification of
differentially methylated markers among cytogenetic risk groups of
acute myeloid leukemia. Epigenetics. 10:526–535. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kim JH, Shim JW, Eum DY, Kim SD, Choi SH,
Yang K, Heo K and Park MT: Downregulation of UHRF1 increases tumor
malignancy by activating the CXCR4/AKT-JNK/IL-6/Snail signaling
axis in hepatocellular carcinoma cells. Sci Rep. 7:27982017.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jung YD, Shim JW, Park SJ, Choi SH, Yang
K, Heo K and Park MT: Downregulation of UHRF1 promotes EMT via
inducing CXCR4 in human cancer cells. Int J Oncol. 46:1232–1242.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ashraf W, Ibrahim A, Alhosin M, Zaayter L,
Ouararhni K, Papin C, Ahmad T, Hamiche A, Mély Y, Bronner C and
Mousli M: The epigenetic integrator UHRF1: On the road to become a
universal biomarker for cancer. Oncotarget. 8:51946–51962.
2017.PubMed/NCBI
|
|
37
|
Cui L, Chen J, Zhang Q, Wang X, Qu J,
Zhang J and Dang S: Up-regulation of UHRF1 by oncogenic Ras
promoted the growth, migration, and metastasis of pancreatic cancer
cells. Mol Cell Biochem. 400:223–232. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Qin L, Dong Z and Zhang JT: Reversible
epigenetic regulation of 14-3-3sigma expression in acquired
gemcitabine resistance by uhrf1 and DNA methyltransferase 1. Mol
Pharmacol. 86:561–569. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang F, Yang YZ, Shi CZ, Zhang P, Moyer
MP, Zhang HZ, Zou Y and Qin HL: UHRF1 promotes cell growth and
metastasis through repression of p16(ink(4)a) in colorectal cancer.
Ann Surg Oncol. 19:2753–2762. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Achour M, Mousli M, Alhosin M, Ibrahim A,
Peluso J, Muller CD, Schini-Kerth VB, Hamiche A, Dhe-Paganon S and
Bronner C: Epigallocatechin-3-gallate up-regulates tumor suppressor
gene expression via a reactive oxygen species-dependent
down-regulation of UHRF1. Biochem Biophys Res Commun. 430:208–212.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Djebali S, Davis CA, Merkel A, Dobin A,
Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F,
et al: Landscape of transcription in human cells. Nature.
489:101–108. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Choudhry H, Harris AL and McIntyre A: The
tumour hypoxia induced non-coding transcriptome. Mol Aspects Med.
47–48. 1–53. 2016.PubMed/NCBI
|
|
43
|
Choudhry H and Mole DR: Hypoxic regulation
of the noncoding genome and NEAT1. Brief Funct Genomics.
15:174–185. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Josse C and Bours V: MicroRNAs and
inflammation in colorectal cancer. Adv Exp Med Biol. 937:53–69.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Vicente R, Noël D, Pers YM, Apparailly F
and Jorgensen C: Deregulation and therapeutic potential of
microRNAs in arthritic diseases. Nat Rev Rheumatol. 12:4962016.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Guedes JR, Santana I, Cunha C, Duro D,
Almeida MR, Cardoso AM, de Lima MC and Cardoso AL: MicroRNA
deregulation and chemotaxis and phagocytosis impairment in
Alzheimer's disease. Alzheimers Dement (Amst). 3:7–17.
2015.PubMed/NCBI
|
|
47
|
Irmak-Yazicioglu MB: Mechanisms of
MicroRNA Deregulation and MicroRNA Targets in Gastric Cancer. Oncol
Res Treat. 39:136–139. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Lujambio A and Lowe SW: The microcosmos of
cancer. Nature. 482:347–355. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ruan X, Zuo Q, Jia H, Chau J, Lin J, Ao J,
Xia X, Liu H, Habib SL, Fu C and Li B: P53 deficiency-induced Smad1
upregulation suppresses tumorigenesis and causes chemoresistance in
colorectal cancers. J Mol Cell Biol. 7:105–118. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Shah MY, Ferrajoli A, Sood AK,
Lopez-Berestein G and Calin GA: microRNA therapeutics in cancer-an
emerging concept. EBioMedicine. 12:34–42. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Li G, Yang F, Gu S, Li Z and Xue M:
MicroRNA-101 induces apoptosis in cisplatin-resistant gastric
cancer cells by targeting VEGF-C. Mol Med Rep. 13:572–578. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Hayes J, Peruzzi PP and Lawler S:
MicroRNAs in cancer: Biomarkers, functions and therapy. Trends Mol
Med. 20:460–469. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Xu J, Wang Z, Li S, Chen J, Zhang J, Jiang
C, Zhao Z, Li J, Li Y and Li X: Combinatorial epigenetic regulation
of non-coding RNAs has profound effects on oncogenic pathways in
breast cancer subtypes. Brief Bioinform. Oct 14–2016.(Epub ahead of
print). View Article : Google Scholar
|
|
54
|
Kaur S, Lotsari-Salomaa JE,
Seppänen-Kaijansinkko R and Peltomäki P: MicroRNA Methylation in
Colorectal Cancer. Adv Exp Med Biol. 937:109–122. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Voorhoeve PM: MicroRNAs: Oncogenes, tumor
suppressors or master regulators of cancer heterogeneity? Biochim
Biophys Acta. 1805:72–86. 2010.PubMed/NCBI
|
|
56
|
Zhou X, Wang X, Huang Z, Wang J, Zhu W,
Shu Y and Liu P: Prognostic value of miR-21 in various cancers: An
updating meta-analysis. PLoS One. 9:e1024132014. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Medina PP, Nolde M and Slack FJ: OncomiR
addiction in an in vivo model of microRNA-21-induced pre-B-cell
lymphoma. Nature. 467:86–90. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Selcuklu SD, Donoghue MT and Spillane C:
miR-21 as a key regulator of oncogenic processes. Biochem Soc
Transac. 37:918–925. 2009. View Article : Google Scholar
|
|
59
|
Favreau AJ, McGlauflin RE, Duarte CW and
Sathyanarayana P: miR-199b, a novel tumor suppressor miRNA in acute
myeloid leukemia with prognostic implications. Exp Hematol Oncol.
5:42016. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Venkataraman S, Birks DK, Balakrishnan I,
Alimova I, Harris PS, Patel PR, Handler MH, Dubuc A, Taylor MD,
Foreman NK and Vibhakar R: MicroRNA 218 acts as a tumor suppressor
by targeting multiple cancer phenotype-associated genes in
medulloblastoma. J Biol Chem. 288:1918–1928. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Boukhari A, Alhosin M, Bronner C, Sagini
K, Truchot C, Sick E, Schini-Kerth VB, André P, Mély Y, Mousli M
and Gies JP: CD47 activation-induced UHRF1 over-expression is
associated with silencing of tumor suppressor gene p16INK4A in
glioblastoma cells. Anticancer Res. 35:149–157. 2015.PubMed/NCBI
|
|
62
|
Arima Y, Hirota T, Bronner C, Mousli M,
Fujiwara T, Niwa S, Ishikawa H and Saya H: Down-regulation of
nuclear protein ICBP90 by p53/p21Cip1/WAF1-dependent DNA-damage
checkpoint signals contributes to cell cycle arrest at G1/S
transition. Genes Cells. 9:131–142. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Alhosin M, Abusnina A, Achour M, Sharif T,
Muller C, Peluso J, Chataigneau T, Lugnier C, Schini-Kerth VB,
Bronner C and Fuhrmann G: Induction of apoptosis by thymoquinone in
lymphoblastic leukemia Jurkat cells is mediated by a p73-dependent
pathway which targets the epigenetic integrator UHRF1. Biochem
Pharmacol. 79:1251–1260. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Wu SM, Cheng WL, Liao CJ, Chi HC, Lin YH,
Tseng YH, Tsai CY, Chen CY, Lin SL, Chen WJ, et al: Negative
modulation of the epigenetic regulator, UHRF1, by thyroid hormone
receptors suppresses liver cancer cell growth. Int J Cancer.
137:37–49. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Soleimani A, Ghanadi K, Noormohammadi Z
and Irani S: The correlation between miR-146a C/G polymorphism and
UHRF1gene expression level in gastric tumor. J Dig Dis. 17:169–174.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Ge M, Gui Z, Wang X and Yan F: Analysis of
the UHRF1 expression in serum and tissue for gastric cancer
detection. Biomarkers. 20:183–188. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Zhou L, Zhao X, Han Y, Lu Y, Shang Y, Liu
C, Li T, Jin Z, Fan D and Wu K: Regulation of UHRF1 by miR-146a/b
modulates gastric cancer invasion and metastasis. FASEB J.
27:4929–4939. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Patnaik SK, Kannisto E, Mallick R and
Yendamuri S: Overexpression of the lung cancer-prognostic miR-146b
microRNAs has a minimal and negative effect on the malignant
phenotype of A549 lung cancer cells. PLoS One. 6:e223792011.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Xiao B, Zhu ED, Li N, Lu DS, Li W, Li BS,
Zhao YL, Mao XH, Guo G, Yu PW and Zou QM: Increased miR-146a in
gastric cancer directly targets SMAD4 and is involved in modulating
cell proliferation and apoptosis. Oncol Rep. 27:559–566.
2012.PubMed/NCBI
|
|
70
|
Yang GL, Zhang LH, Bo JJ, Chen HG, Cao M,
Liu DM and Huang YR: UHRF1 is associated with tumor recurrence in
non-muscle-invasive bladder cancer. Med Oncol. 29:842–847. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Zhang Y, Huang Z, Zhu Z, Zheng X, Liu J,
Han Z, Ma X and Zhang Y: Upregulated UHRF1 promotes bladder cancer
cell invasion by epigenetic silencing of KiSS1. PLoS One.
9:e1042522014. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Ying L, Lin J, Qiu F, Cao M, Chen H, Liu Z
and Huang Y: Epigenetic repression of regulator of G-protein
signaling 2 by ubiquitin-like with PHD and ring-finger domain 1
promotes bladder cancer progression. FEBS J. 282:174–182. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Unoki M, Kelly JD, Neal DE, Ponder BA,
Nakamura Y and Hamamoto R: UHRF1 is a novel molecular marker for
diagnosis and the prognosis of bladder cancer. Br J Cancer.
101:98–105. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Wang X, Wu Q, Xu B, Wang P, Fan W, Cai Y,
Gu X and Meng F: miR-124 exerts tumor suppressive functions on the
cell proliferation, motility and angiogenesis of bladder cancer by
fine-tuning UHRF1. FEBS J. 282:4376–4388. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Matsushita R, Yoshino H, Enokida H, Goto
Y, Miyamoto K, Yonemori M, Inoguchi S, Nakagawa M and Seki N:
Regulation of UHRF1 by dual-strand tumor-suppressor microRNA-145
(miR-145-5p and miR-145-3p): Inhibition of bladder cancer cell
aggressiveness. Oncotarget. 7:28460–28487. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Xie W, Li X, Chen X and Huang S and Huang
S: Decreased expression of PRDM2 (RIZ1) and its correlation with
risk stratification in patients with myelodysplastic syndrome. Br J
Haematol. 150:242–244. 2010.PubMed/NCBI
|
|
77
|
Kim KC, Geng L and Huang S: Inactivation
of a histone methyltransferase by mutations in human cancers.
Cancer Res. 63:7619–7623. 2003.PubMed/NCBI
|
|
78
|
Wotschofsky Z, Gummlich L, Liep J, Stephan
C, Kilic E, Jung K, Billaud JN and Meyer HA: Integrated microRNA
and mRNA signature associated with the transition from the locally
confined to the metastasized clear cell renal cell carcinoma
exemplified by miR-146-5p. PLoS One. 11:e01487462016. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Ma J, Peng J, Mo R, Ma S, Wang J, Zang L,
Li W and Fan J: Ubiquitin E3 ligase UHRF1 regulates p53
ubiquitination and p53-dependent cell apoptosis in clear cell renal
cell carcinoma. Biochem Biophys Res Commun. 464:147–153. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Li YL, Wang J, Zhang CY, Shen YQ, Wang HM,
Ding L, Gu YC, Lou JT, Zhao XT, Ma Z and Jin YX: MiR-146a-5p
inhibits cell proliferation and cell cycle progression in NSCLC
cell lines by targeting CCND1 and CCND2. Oncotarget. 7:59287–59298.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Sun Q, Zhao X, Liu X, Wang Y, Huang J,
Jiang B, Chen Q and Yu J: miR-146a functions as a tumor suppressor
in prostate cancer by targeting Rac1. Prostate. 74:1613–1621. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Riquelme I, Tapia O, Leal P, Sandoval A,
Varga MG, Letelier P, Buchegger K, Bizama C, Espinoza JA, Peek RM,
et al: miR-101-2, miR-125b-2 and miR-451a act as potential tumor
suppressors in gastric cancer through regulation of the
PI3K/AKT/mTOR pathway. Cell Oncology (Dordr). 39:23–33. 2016.
View Article : Google Scholar
|
|
83
|
Farhadi E, Zaker F, Safa M and Rezvani MR:
miR-101 sensitizes K562 cell line to imatinib through Jak2
downregulation and inhibition of NF-κB target genes. Tumour Biol.
37:14117–14128. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Goto Y, Kurozumi A, Nohata N, Kojima S,
Matsushita R, Yoshino H, Yamazaki K, Ishida Y, Ichikawa T, Naya Y
and Seki N: The microRNA signature of patients with sunitinib
failure: Regulation of UHRF1 pathways by microRNA-101 in renal cell
carcinoma. Oncotarget. 7:59070–59086. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Walter A, Etienne-Selloum N, Brasse D,
Khallouf H, Bronner C, Rio MC, Beretz A and Schini-Kerth VB: Intake
of grape-derived polyphenols reduces C26 tumor growth by inhibiting
angiogenesis and inducing apoptosis. FASEB J. 24:3360–3369. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Kofunato Y, Kumamoto K, Saitou K, Hayase
S, Okayama H, Miyamoto K, Sato Y, Katakura K, Nakamura I, Ohki S,
et al: UHRF1 expression is upregulated and associated with cellular
proliferation in colorectal cancer. Oncol Rep. 28:1997–2002. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Zhu M, Xu Y, Ge M, Gui Z and Yan F:
Regulation of UHRF1 by microRNA-9 modulates colorectal cancer cell
proliferation and apoptosis. Cancer Sci. 106:833–839. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Bandres E, Agirre X, Bitarte N, Ramirez N,
Zarate R, Roman-Gomez J, Prosper F and Garcia-Foncillas J:
Epigenetic regulation of microRNA expression in colorectal cancer.
Int J Cancer. 125:2737–2743. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Cekaite L, Rantala JK, Bruun J, Guriby M,
Agesen TH, Danielsen SA, Lind GE, Nesbakken A, Kallioniemi O, Lothe
RA and Skotheim RI: MiR-9, −31, and −182 deregulation promote
proliferation and tumor cell survival in colon cancer. Neoplasia.
14:868–879. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Lu MH, Huang CC, Pan MR, Chen HH and Hung
WC: Prospero homeobox 1 promotes epithelial-mesenchymal transition
in colon cancer cells by inhibiting E-cadherin via miR-9. Clin
Cancer Res. 18:6416–6425. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Unoki M, Daigo Y, Koinuma J, Tsuchiya E,
Hamamoto R and Nakamura Y: UHRF1 is a novel diagnostic marker of
lung cancer. Br J Cancer. 103:217–222. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Wu H, Meng S, Xu Q, Wang X, Wang J, Gong
R, Song Y, Duan Y and Zhang Y: Gene expression profiling of lung
adenocarcinoma in Xuanwei, China. Eur J Cancer Prev. 25:508–517.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Deng W, Yan M, Yu T, Ge H, Lin H, Li J,
Liu Y, Geng Q, Zhu M, Liu L, et al: Quantitative proteomic analysis
of the metastasis-inhibitory mechanism of miR-193a-3p in non-small
cell lung cancer. Cell Physiol Biochem. 35:1677–1688. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Daskalos A, Oleksiewicz U, Filia A,
Nikolaidis G, Xinarianos G, Gosney JR, Malliri A, Field JK and
Liloglou T: UHRF1-mediated tumor suppressor gene inactivation in
nonsmall cell lung cancer. Cancer. 117:1027–1037. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Yu T, Li J, Yan M, Liu L, Lin H, Zhao F,
Sun L, Zhang Y, Cui Y, Zhang F, et al: MicroRNA-193a-3p and −5p
suppress the metastasis of human non-small-cell lung cancer by
downregulating the ERBB4/PIK3R3/mTOR/S6K2 signaling pathway.
Oncogene. 34:413–423. 2015. View Article : Google Scholar : PubMed/NCBI
|
